Home › Funds › Integral Health Asset Management, LLC › ARWR

Integral Health Asset Management, LLC position in ARWR

ARROWHEAD PHARMACEUTICALS IN · Health Care

Integral Health Asset Management, LLC reported holding 200,000 shares of ARWR (ARROWHEAD PHARMACEUTICALS IN) in its Q2 2026 13F filing — a position valued at US$16.3M, representing 0.73% of its reported portfolio and ranking #42 among its reported holdings. Integral Health Asset Management, LLC has disclosed ARWR holdings in 6 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)200.00K sh
Reported value held$16.30M
Portfolio Weight0.73%
First reportedQ4 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Integral Health Asset Management, LLC's ARWR position evolved

Integral Health Asset Management, LLC first disclosed a stake in ARWR in Q4 2024 at 275,000 shares (US$5.2M). The position peaked in Q1 2026 at 300,000 shares, worth US$18.8M. Across 6 filings, Integral Health Asset Management, LLC increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 200,000 shares valued at US$16.3M — a reduction of -100,000 shares quarter over quarter.. Notable position changes include a 36% trim in Q1 2025 (shares rose 24% over the following quarter), a 56% trim in Q4 2025 (shares fell 6% over the following quarter), a 200% increase in Q1 2026 (shares rose 30% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 275.00K $5.17M New
Q1 2025 175.00K $2.23M Reduce
Q3 2025 225.00K $7.76M New
Q4 2025 100.00K $6.64M Reduce
Q1 2026 300.00K $18.81M Add
Q2 2026 200.00K $16.30M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ARWR and 13F data

ARWR (ARROWHEAD PHARMACEUTICALS IN) is a Health Care company. 53 other funds we track also report a position in ARWR — the largest reported positions include Avoro Capital Advisors LLC (US$925.6M), FRED ALGER MANAGEMENT, LLC (US$269.1M), BAKER BROS. ADVISORS LP (US$162.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ARWR

All ARWR fund holders →

FAQ

How long has Integral Health Asset Management, LLC held ARWR?

Integral Health Asset Management, LLC has disclosed ARWR holdings in 6 of the last 7 reported quarters, going back to Q4 2024.

What is Integral Health Asset Management, LLC's current position in ARWR?

As of Q2 2026, Integral Health Asset Management, LLC holds 200.00K shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), valued at $16.30M, representing 0.73% of its reported portfolio and ranking #42.

Has Integral Health Asset Management, LLC been buying or selling ARWR?

In the latest 13F filing (Q2 2026), Integral Health Asset Management, LLC reduced its position in ARWR. The position peaked in Q1 2026 at 300.00K shares.

Which other funds hold ARWR?

Other major institutional holders of ARWR include Avoro Capital Advisors LLC, FRED ALGER MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.